{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:15:48Z","timestamp":1762254948049,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmcl.2024.129936","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T02:09:45Z","timestamp":1724897385000},"page":"129936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["N-acyl-4-arylaminopiperidines: Design and synthesis of a potential antimicrobial scaffold"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-9448","authenticated-orcid":false,"given":"Eduardo","family":"Hern\u00e1ndez-V\u00e1zquez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Ram\u00edrez-Trinidad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar E.","family":"Tovar-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A.","family":"Rivera Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Huerta-Salazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129936_b0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bmcl.2024.129936_b0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.vetmic.2014.02.035","article-title":"The resistance tsunami, antimicrobial stewardship, and the golden age of microbiology","volume":"171","author":"Prescott","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.bmcl.2024.129936_b0015","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial Resistance: Implications and Costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.bmcl.2024.129936_b0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41564-019-0357-1","article-title":"Drug repurposing for antimicrobial discovery","volume":"4","author":"Farha","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmcl.2024.129936_b0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1359-6446(01)01774-3","article-title":"Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery","volume":"6","author":"Payne","year":"2001","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2024.129936_b0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev.micro.55.1.305","article-title":"Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug Discovery","volume":"55","author":"Campbell","year":"2001","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.bmcl.2024.129936_b0035","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.1002\/anie.201915407","article-title":"The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl-Acyl Carrier Protein Binding Site of FabI","volume":"59","author":"Fage","year":"2020","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2024.129936_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112757","article-title":"FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors","volume":"208","author":"Rana","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129936_b0045","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/00397910903026731","article-title":"One-Pot Reductive Amination of Carbonyl Compounds Using Sodium Borohydride-Amberlyst 15","volume":"40","author":"Alinezhad","year":"2010","journal-title":"Synth Commun"},{"key":"10.1016\/j.bmcl.2024.129936_b0050","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.apjtb.2017.01.019","article-title":"Nosocomial infections: Epidemiology, prevention, control and surveillance","volume":"7","author":"Khan","year":"2017","journal-title":"Asian Pac J Trop Biomed"},{"key":"10.1016\/j.bmcl.2024.129936_b0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1021\/acsinfecdis.6b00123","article-title":"Benzimidazole-based FabI inhibitors: A promising novel scaffold for anti-staphylococcal drug development","volume":"3","author":"Mistry","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmcl.2024.129936_b0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/pro.4252","article-title":"Characterization of protein\u2013ligand binding interactions of enoyl-ACP reductase (FabI) by native MS reveals allosteric effects of coenzymes and the inhibitor triclosan","volume":"31","author":"Joyner","year":"2022","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmcl.2024.129936_b0065","doi-asserted-by":"crossref","first-page":"5865","DOI":"10.1128\/AAC.01411-12","article-title":"Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor","volume":"56","author":"Kaplan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2024.129936_b0070","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/acscentsci.2c00598","article-title":"An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections","volume":"8","author":"Parker","year":"2022","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.bmcl.2024.129936_b0075","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/07391102.2023.2200571","article-title":"In-silico identification of potential inhibitors against FabI protein in Klebsiella pneumoniae","volume":"42","author":"Khan","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmcl.2024.129936_b0080","first-page":"1668789","article-title":"Klebsiella pneumonia and Its Antibiotic Resistance: A Bibliometric Analysis","volume":"2022","author":"Li","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.bmcl.2024.129936_b0085","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2024.129936_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00894-016-3192-9","article-title":"Docking and molecular dynamics studies on triclosan derivatives binding to FabI","volume":"23","author":"Yang","year":"2017","journal-title":"J Mol Model"},{"key":"10.1016\/j.bmcl.2024.129936_b0095","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/acsmedchemlett.8b00612","article-title":"N-Benzylanilines as Fatty Acid Synthesis Inhibitors against Biofilm-related Methicillin-resistant Staphylococcus aureus","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Med Chem Lett"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400338X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2400338X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T21:43:10Z","timestamp":1726350190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2400338X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":19,"alternative-id":["S0960894X2400338X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129936","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acyl-4-arylaminopiperidines: Design and synthesis of a potential antimicrobial scaffold","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129936"}}